Role of EGFR, HER2 and PIK3CA alterations in male breast cancer

被引：0
|
作者：
Rizzolo, P. [1 ]
Silvestri, V. [1 ]
Falchetti, M. [1 ]
Zanna, I. [2 ]
Palli, D. [2 ]
Ottini, L. [1 ]
机构：
[1] Univ Roma La Sapienza, Rome, Italy
[2] Canc Prevent & Res Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 05期
关键词：
D O I：
10.1016/S1359-6349(10)70901-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
92
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [11] Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma
    Hayes, Monica Prasad
    Douglas, Wayne
    Ellenson, Lora Hedrick
    GYNECOLOGIC ONCOLOGY, 2009, 113 (03) : 370 - 373
  • [12] PIK3CA mutated, hormonal receptors and HER2: individual targets but partnered in the escape to targeted therapy in breast cancer
    Pinto, Joseph A.
    Gomez, Henry L.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S789 - S793
  • [13] In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer
    Janiszewska, Michalina
    Liu, Lin
    Almendro, Vanessa
    Kuang, Yanan
    Paweletz, Cloud
    Sakr, Rita A.
    Weigelt, Britta
    Hanker, Ariella B.
    Chandarlapaty, Sarat
    King, Tari A.
    Reis-Filho, Jorge S.
    Arteaga, Carlos L.
    Park, So Yeon
    Michor, Franziska
    Polyak, Kornelia
    NATURE GENETICS, 2015, 47 (10) : 1212 - +
  • [14] In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer
    Michalina Janiszewska
    Lin Liu
    Vanessa Almendro
    Yanan Kuang
    Cloud Paweletz
    Rita A Sakr
    Britta Weigelt
    Ariella B Hanker
    Sarat Chandarlapaty
    Tari A King
    Jorge S Reis-Filho
    Carlos L Arteaga
    So Yeon Park
    Franziska Michor
    Kornelia Polyak
    Nature Genetics, 2015, 47 : 1212 - 1219
  • [15] Targeting PIK3CA in HER2-positive breast cancer: what are the opportunities and the challenges?
    Zouein, Joseph
    Noujaim, Charbel
    Kourie, Hampig Raphael
    BIOMARKERS IN MEDICINE, 2021, 15 (09) : 609 - 613
  • [16] Initiating breast cancer by PIK3CA mutation
    Miller, Todd W.
    BREAST CANCER RESEARCH, 2012, 14 (01):
  • [17] Initiating breast cancer by PIK3CA mutation
    Todd W Miller
    Breast Cancer Research, 14
  • [18] Exon 9 and exon 20 mutations in PIK3CA confer resistance to HER2 inhibitors in HER2-overexpressing breast cancer cells.
    Rexer, B. N.
    Chakrabarty, A.
    Rinehart, C.
    Chang, J.
    Engelman, J.
    Arteaga, C. L.
    CANCER RESEARCH, 2009, 69 (02) : 266S - 267S
  • [19] Epigenetic Therapy in Hormone Positive Breast Cancer: The Role of PIK3CA
    Blawski, Ryan
    Toska, Eneda
    CURRENT BREAST CANCER REPORTS, 2025, 17 (01)
  • [20] The role of PIK3CA mutations in the development of breast cancer (a literature review)
    Pryvalova, A. O.
    Vynnychenko, I. O.
    Harbuzova, V. Yu
    Vynnychenko, O., I
    Moskalenko, Yu, V
    ZAPOROZHYE MEDICAL JOURNAL, 2020, 22 (04) : 554 - 560
12345